IP Library › Granted Patent US 9,968,705
Granted Patent B2
US 9,968,705 · App. 14/348,273 · Granted May 15, 2018

Bioscaffolds for formation of motor endplates and other specialized tissue structures

Inventors: George J. Christ (Lewisville, NC); Justin M. Saul (Oxford, OH); John B Scott (Winston-Salem, NC); Benjamin T. Corona (Converse, TX); Benjamin S. Harrison (Tobaccoville, NC); Catherine Ward (San Antonio, TX)
Assignee: Wake Forest University Health Sciences
A61L27/227A61K31/27A61K31/341A61K31/465A61K33/24A61K33/26A61K33/38A61L27/3604A61L27/3826A61L27/3873A61L27/446A61L27/48A61L27/50A61L27/52A61L27/54A61L27/58C12N5/0658G01N33/553A61K38/17A61L2300/252A61L2300/622A61L2430/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,968,705
App. No.
14/348,273
Granted
May 15, 2018
Kind
B2
Abstract

Provided herein are scaffolds and methods useful to promote the formation of functional clusters on a tissue, for example, motor endplates (MEPs) or a component thereof on skeletal muscle cells or tissue, as well as the use of scaffolds so produced for repairing a tissue injury or defect.

Claims (13)

1. A method of culturing organized skeletal muscle tissue from precursor muscle cells, comprising cyclically stretching and relaxing said muscle cells on a scaffold in vitro for a time sufficient to produce said organized skeletal muscle tissue, and further comprising:

including agrin at separate and discrete locations in or on said scaffold, said agrin provided in an amount effective to promote the formation of aggregated acetylcholine receptors in said organized skeletal muscle adjacent to one or more of said separate and discrete locations.

2. The method of claim 1 , wherein said scaffold comprises fibrin, collagen, agarose, cellulose, alginate, agarose, keratin, hydroxymethyl cellulose, or poly(hydroxyethylmethacrylate).

3. The method of claim 1 , wherein said precursor muscle cells are myoblast cells or satellite cells.

4. The method of claim 1 , further comprising the step of isolating precursor muscle cells from a donor tissue.

5. The method of claim 1 , wherein said scaffold further comprises one or more agents selected from: heparin-binding growth-associated molecule (HB-GAM), muscarine, acetylcholine receptor antibodies, carbachol, and nicotine.

6. The method of claim 1 , wherein said tissue is suturable.

7. The method of claim 1 , wherein said step of including agrin is carried out by including beads in or on said scaffold, with said beads comprising said agrin.

8. The method of claim 7 , wherein said beads are microbeads.

9. The method of claim 7 , wherein said separate and discrete locations are provided at an approximately 1:1, 1:2, 1:3, 1:4, 1:5, 5:1, 4:1, 3:1, or 2:1 ratio with respect to formed myotubes in said organized skeletal muscle tissue.

10. The method of claim 7 , wherein said beads comprises polystyrene, poly(ethylene), poly(lactic acid), poly(glycolic acid), or poly(lactic-co-glycol acid).

11. The method of claim 7 , wherein said beads comprise gold, silver, or iron oxide.

12. The method of claim 7 , wherein said agrin is incorporated onto said beads though covalent coupling.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2014
From: CHRIST, GEORGE J.; SAUL, JUSTIN M.; SCOTT, JOHN B.; CORONA, BENJAMIN T.; HARRISON, BENJAMIN S.; WARD, CATHERINE
To: WAKE FOREST UNIVERSITY HEALTH SCIENCES
Reel/Frame 033286/0766 →
Continuity (2)
Provisional Application 61541652 · Sep 30, 2011
Related Publication 20140234388A1 · Aug 21, 2014